- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03486145
Effect of Nitrate-rich Fruit and Vegetable Supplement on Blood Pressure
March 27, 2018 updated by: Carol Johnston, Arizona State University
Nitrate-rich Fruit and Vegetable Supplement and Blood Pressure in Normotensive Healthy Young Males: a Randomized, Double-blinded, Placebo-controlled Trial
It is hypothesized that the daily supplementation of a nitrate-rich, two-ounce fruit and vegetable energy supplement (Isagenix International LLC) by healthy young adults with a would increase circulating nitrates and improve cardiovascular parameters compared to a nitrate-deficient placebo (prune juice).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Endothelial cells of the peripheral vasculature are key sources of vasoactive factors regulating healthy blood pressure.
One of the primary vasodilatory factors released from these cells is nitric oxide (NO).
Production of NO is stimulated both through enzymatic-dependent mechanisms via NO synthase, as well as from dietary intake of nitrate-containing foods or supplements that increase NO bioavailability.
This study examined whether the daily consumption of a nitrate-rich, two-ounce fruit and vegetable energy supplement (Isagenix International LLC) would increase circulating nitrates and improve cardiovascular parameters compared to a nitrate-deficient placebo (prune juice).
Healthy male adults aged 18-40y (n=45) were recruited to participate in this longitudinal double-blind, placebo-controlled, randomized clinical trial.
Subjects maintained their typical diet and physical activity patterns during the study.
Anthropometric and cardiovascular (blood pressure and flow-mediated dilation (FMD)) parameters, along with plasma nitrates and nitrites were measured at baseline and after one and two weeks of supplementation.
Subjects also completed questionnaires on sleep quality and mood.
It is hypothesized that the nitrate-rich FVS supplement will provide a good source of dietary nitrates and effectively reduced blood pressure in normotensive, healthy young males.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Arizona State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
• healthy men aged 18-40y
Exclusion Criteria:
- hypo- or hypertension (blood pressure < 100/65 or >140/90
- cigarette use within past year
- food allergies
- specific medication use (nitroglycerin, beta-blockers, calcium channel blockers),
- unwillingness to drink juice concentrates and follow study restrictions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: FVS (fruit and vegetable juice supplement)
The supplement contained ≈ 260-280 mg or 4 mmoles nitrate per two-ounce serving along with ≈ 51 mg total polyphenols.
The FVS contains 7880 mg of a proprietary blend of beet root extract (Beta vulgaris), celery stem and leaf extract (Apium graveolens), red spinach leaf extract (Amaranthus dubius), stevia leaf extract (Stevia rebaudiana), and a fruit and vegetable extract blend (green tea leaf, red grape, white grape, bilberry, carrot, grapefruit, papaya, pineapple, strawberry, apple, apricot, cherry, orange, broccoli, green cabbage leaf, onion, garlic, black current, asparagus, tomato, olive and cucumber).
Virtually all of the nitrates in FVS derive from the beet, celery, and red spinach extracts.
|
FVS was provided by Isagenix International LLC in identically sealed bottles labeled labeled "B".
Subjects were not told which supplement they received.
Each bottle contained one serving (two ounces) of the supplement.
|
|
PLACEBO_COMPARATOR: PRU (prune juice)
The placebo supplement was prune juice (Sunsweet brand 100% prune juice) (PRU).
Prune juice was selected based on its very similar caloric and sugar content, its high antioxidant and phenolic profile, but low nitrate content.
The prune juice contained <0.6 mg nitrates and 133 mg total polyphenols per two-ounce serving.
|
PRU was provided by Isagenix International LLC in identically sealed bottles labeled labeled "A".
Subjects were not told which supplement they received.
Each bottle contained one serving (two ounces) of the supplement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma nitrates and nitrites
Time Frame: Two week change in concentration (week 2 - baseline)
|
The primary objective of this study was to examine the short-term effects of a novel, two-ounce nitrate-rich fruit and vegetable supplement (FVS) (AMPED NOx, Isagenix International LLC) on plasma nitrates and nitrites in healthy young men.
|
Two week change in concentration (week 2 - baseline)
|
|
Flow-mediated dilation
Time Frame: Two week change in dilation (week 2 - baseline)
|
The primary objective of this study was to examine the short-term effects of a novel, two-ounce nitrate-rich fruit and vegetable supplement (FVS) (AMPED NOx, Isagenix International LLC) on endothelial function in healthy young men.
|
Two week change in dilation (week 2 - baseline)
|
|
Blood pressure
Time Frame: Two week change in blood pressure (week 2 - baseline)
|
The primary objective of this study was to examine the short-term effects of a novel, two-ounce nitrate-rich fruit and vegetable supplement (FVS) (AMPED NOx, Isagenix International LLC) on blood pressure in healthy young men.
|
Two week change in blood pressure (week 2 - baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of athletic status on endothelial function
Time Frame: Two week change in flow mediated dilation (week 2 - baseline) by athletic status
|
To explore whether athletic status modified the flow mediated dilation response to the supplement athletes
|
Two week change in flow mediated dilation (week 2 - baseline) by athletic status
|
|
Effect of athletic status on blood pressure
Time Frame: Two week change in blood pressure (week 2 - baseline) by athletic status
|
To explore whether athletic status modified the blood pressure response to supplementation
|
Two week change in blood pressure (week 2 - baseline) by athletic status
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FMD and mood
Time Frame: Two week change in FMD and mood
|
The association of FMD with mood
|
Two week change in FMD and mood
|
|
FMD and sleep quality
Time Frame: Two week change in FMD and sleep quality
|
The association of FMD with sleep quality
|
Two week change in FMD and sleep quality
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 16, 2015
Primary Completion (ACTUAL)
March 30, 2016
Study Completion (ACTUAL)
March 30, 2016
Study Registration Dates
First Submitted
June 8, 2017
First Submitted That Met QC Criteria
March 27, 2018
First Posted (ACTUAL)
April 3, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 3, 2018
Last Update Submitted That Met QC Criteria
March 27, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMPED1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Blood Pressure
-
Indena S.p.ARecruitingHigh-normal Blood PressureItaly
-
GE HealthcareTerminatedBlood Pressure (Low, Normal, High)United States
-
Dow University of Health SciencesCompletedCognitive Change | Blood Pressure | Blood Glucose, HighPakistan
-
The Cleveland ClinicNot yet recruitingHypertension | Blood Pressure, High | Hypertension (HTN) | Blood Pressure ControlUnited States
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Sky LabsSamsung Medical CenterRecruitingHypertension | Blood Pressure | Hypotension | Blood Pressure, High | Blood Pressure, LowKorea, Republic of
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
Centre Hospitalier Universitaire de la GuadeloupeRecruiting
-
Ouraring Inc.Recruiting
-
The University of NorthamptonCompletedHypertension | Blood Pressure, HighUnited Kingdom
Clinical Trials on fruit and vegetable juice supplement
-
Northumbria UniversityCompletedCognitive Impairment | Cerebrovascular CirculationUnited Kingdom
-
University of California, Los AngelesCompletedIntestinal Bacteria Flora DisturbanceUnited States
-
Birmingham Community Healthcare NHSNSA, LLCCompleted
-
Green BeatMedical University of GrazActive, not recruitingCardiovascular Diseases | Aging | Overweight or ObesityAustria
-
Biofortis, Merieux NutriSciencesRecruitingMitochondrial FunctionsUnited States
-
Wholesome WaveYale-Griffin Prevention Research Center; One Community HealthCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | PovertyUnited States
-
St. Catherine UniversityUniversity of MinnesotaCompletedCardiovascular DiseasesUnited States
-
Nemours Children's ClinicNSA, LLCCompleted
-
Albert Einstein Healthcare NetworkRobert Wood Johnson FoundationCompletedFocus of the Study is on the Use of Incentives to Promote | Healthier Eating in Low-income CommunitiesUnited States
-
Oregon Health and Science UniversityCompletedHyperlipidemiasUnited States